With respect to EG.5 antibody levels, other carcinomas showed the highest pVNT50 (41.0 [19.6, 71.1]), followed by prostate carcinoma (37.0 [15.8, 55.3]); lung carcinoma displayed the lowest pVNT50 (21.7 [4.0, 81.6]) (Figure 4). This evidence concerns the gene KIF11 and carcinoma.